Gastroenterology
Volume 122, Issue 1 , Pages 228-230 , January 2002

Unsettling facts of life: Bacterial commensalism, epithelial adherence, and inflammatory bowel disease

References 

  1. Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microflora. 1. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology. 1967;53:845–855
  2. Holdeman LV, Good IJ, Moore WEC. Human fecal flora: variation in bacterial composition within individuals and possible effect of emotional stress. Appl Environ Microbiol. 1976;31:359–375
  3. Finegold SM, Sutter VL. Fecal flora in different populations, with special reference to diet. Am J Clin Nutr. 1978;1:S116–S122
  4. Relman DA. The search for unrecognized pathogens. Science. 1999;284:1308–1311
  5. Wilson KH, Blitchington RB. Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol. 1996;62:2273–2278
  6. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol. 2000;66:2578–2588
  7. Stephen AM, Cummings JH. The microbial contribution to human faecal mass. J Med Microbiol. 1980;13:45–56
  8. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107–133
  9. Macfarlane GT, Cummings JH. The colonic flora, fermentation, and large bowel digestive function. In:  Phillips SF,  Pemberton JH,  Shorter RG editor. The large intestine: physiology, pathophysiology, and disease. New York: Raven Press; 1991;p. 51–92
  10. Beutler B. Autoimmunity and apoptosis: the Crohn's connection. Immunity. 2001;15:5–14
  11. Sartor RB. Review article: How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation?. Aliment Pharmacol Ther. 1997;11Suppl(3):89–96
  12. de Kievit TR, Iglewski BH. Bacterial quorum sensing in pathogenic relationships. Infect Immun. 2000;68:4839–4849
  13. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305–309
  14. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology. 2001;120:622–635
  15. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291:881–884
  16. Hooper LV, Gordon JI. Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity. Glycobiology. 2001;11:1R–10R
  17. Godaly G, Bergsten G, Frendeus B, Hang L, Hedlund M, Karpman D, et al. Innate defences and resistance to gram negative mucosal infection. Adv Exp Med Biol. 2000;485:9–24
  18. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44–54
  19. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 2001;357:1925–1928
  20. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603–606
  21. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599–603
  22. Burke DA, Axon AT. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ. 1988;297:102–104
  23. Giaffer MH, Holdsworth CD, Duerden BI. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 1992;33:646–650
  24. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998;115:1405–1413
  25. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut. 2000;47:589–594
  26. Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, et al. Peroxynitrite-induced rat colitis–a new model of colonic inflammation. Gastroenterology. 1993;105:1681–1688
  27. Munkholm P. Crohn's disease–Occurrence, course and prognosis–An epidemiologic cohort-study. Dan Med Bull. 1997;44:287–302
  28. Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol. 2001;67:561–568
  29. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, et al. Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996;98:945–953
  30. Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun. 1997;65:3126–3131
  31. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun. 1998;66:5157–5166
  32. Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001;69:2277–2285

☆ Address requests for reprints to: Jonathan Braun, M.D., Ph.D., Department of Pathology and Lab Medicine, UCLA School of Medicine CHS 13-222, Los Angeles, California 90095-1732. e-mail: jbraun@mednet.ucla.edu; fax: (310) 825-5674.

PII: S0016-5085(02)70166-2

Gastroenterology
Volume 122, Issue 1 , Pages 228-230 , January 2002

Article Tools